CANNT 2021 Virtual Conference Abstract Submissions

CANNT-ACITN invites you to join us for the 2021 Virtual Conference, October 19-December 2, 2021. Presentations will take place every Tuesday and Thursday from 2:30 – 3:30 p.m. ET and 6:30 – 7:30 p.m. ET.

ORAL PRESENTATIONS will be 30-minute time slots (includes Q&A).

POSTER PRESENTATIONS will be posted online in Virtual Poster format. Virtual Poster Presentations online will include a pdf of your full poster and a pre-recorded presentation of your abstract, approximately 3-4 minutes long.

Topics of interest may include but are not limited to:

  • COVID-19 in Nephrology
  • Clinical Research
  • Innovative Projects and Solutions
  • Ethics and Elderly Care
  • Case Presentations and Clinical Reviews
  • Transplant
  • Mental Health and CKD
  • Cardiovascular Disease and CKD
  • Future Directions of CKD and Treatment
  • Pregnancy with Renal Disease
  • Pediatrics
  • Medical Assistance in Dying
  • Technical Advances in Dialysis Equipment
  • Home Therapies.

All abstract submissions must be evidence-based.
All abstracts must be submitted online using the online submission form as well as uploaded as a Word Doc. attachment at the end of the submission form in the outlined format.

Abstract Guidelines

Abstracts should be no longer than 250 words (no pictures) and should include:

1) Abstract Title

  • must accurately reflect the content of the presentation
  • must be formatted in sentence case (capitalize first word and remaining words begin in lower case)

2) Authors and Affiliations

  • must be included under the title and formatted as follows:
    Anne L. Smitha, Robert G. Jonesa,b.
    aDepartment of Nephrology, University of Toronto, Toronto, ON; bDepartment of Nephrology, University of Alberta Hospital, Edmonton, AB.
    Underline the name and initials of the presenter.

3) Abstract Text

  • should be no longer than 250 words
  • should be as informative as possible
  • define all abbreviations the first time they appear in the abstract
  • use only the generic names of drugs
  • do not identify companies and/or products in the body or title of the abstract

If research-based, must include below headings:

  • purpose of study
  • methods
  • results
  • conclusions
  • implications for nephrology care

If practice/education-based, must include below headings:

  • purpose of the project
  • description
  • evaluation/outcome
  • implications for nephrology practice/education

Only COMPLETE submissions received by MAY 31 2021 will be considered.

  • All correspondence will be with the first author only.
  • Acceptance of abstract does not waive attendance fees (registration).
  • Notification regarding selection decisions will be provided by July 5, 2021.
  • Should the abstract be selected for presentation, the author(s) authorize(s) the publication of the abstract submitted for publication in the CANNT-ACITN Journal.
  • The presentation shall not make comparison to companies or products for any purposes of product marketing, nor will topics or materials used discredit companies or products.
  • The abstract, and associated authors, should make full disclosure of corporate employment and/or funding sources.
  • Abstracts not in the required format will be returned to the author for revision.
  • The language of abstract submission will be the language of presentation, if selected.